Skip to content

Novel Technique Versus Conventional Subepithelial Connective Tissue Graft in Treatment of Ridge Contour Defects

Evaluation of a Novel Technique Versus Conventional Subepithelial Connective Tissue Graft in Treatment of Ridge Contour Defects. A Randomized Controlled Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06435780
Enrollment
50
Registered
2024-05-30
Start date
2023-04-01
Completion date
2026-12-31
Last updated
2026-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Defect in Alveolar Ridge

Keywords

ridge contour defect, soft tissue graft, Rolling Technique, Connective tissue graft, Subepithelial palatal graft, Seibert Class I

Brief summary

The aim of the study is to clinically and radiographically evaluate and compare two techniques to augment soft tissues: the conventional subepithelial connective tissue graft technique and a novel denuded interpositional pedicled rolled flap technique (DIPRF) These techniques will be used to augment edentulous ridges that are recommended for rehabilitation by an implant or a fixed restoration.

Detailed description

Fifty patients with soft tissue ridge contour defects in the maxillary premolar region and recommended for rehabilitation by an implant or a fixed restoration will be enrolled. Patients will be allocated randomly into two groups; group 1 (test group) will have augmentation for their soft tissue by a novel Denuded interpositional pedicled rolled flap technique (DIPRF); group 2 (control group) will be augmented by the conventional subepithelial connective tissue graft technique. Clinical volumetric change evaluation and ridge thickness analysis using digitally calibrated casts and CBCT analysis with a fusion software will be performed for every site as well as periodontal evaluation and patient centered outcomes, including pain and satisfaction after the procedure will be recorded for both techniques. For each site, an impression will be used to pour a cast that will be digitally scanned and vertical and horizontal ridge contours dimensions(tissue volumetric changes) will be recorded. These measurements will be obtained before the surgical procedure, 2 weeks, and 3 and 6 months post-surgical. CBCT analysis will be performed pre-operatively to confirm the diagnosis and eligibility of the case as having only soft tissue defect without bone defects, and 6 months postoperatively to analyze the amount of soft tissue gain in the two groups.

Interventions

PROCEDUREDIPRF

Denuded interpositional pedicled rolled flap technique

Sponsors

Misr International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. Adults above the age of 18 to 50 years. 2. Males and females as confirmed by asking the female patients about whether they are pregnant or not 3. Patient's with Seibert classification class I requiring future rehabilitation of one or more premolar region and sound adjacent teeth. 4. Soft tissue thickness on the palatal tissues more than 6mm at the site of harvesting the graft. 5. Presence of Mandibular posterior teeth opposing the tooth to be replaced for occlusion. 6. Clinically healthy soft tissues with no signs of clinical pathology of the soft tissue. 7. Good oral hygiene. 8. Patient accepts to sign an informed consent. 9. ASA I or ASA II Patient.

Exclusion criteria

1. Patients with ridge defects due to bone defect 2. Smoker patients who smoke more than 10 cigarettes per day 3. Pregnant females

Design outcomes

Primary

MeasureTime frameDescription
Ridge contour thickness gain6 monthsRidge contour will be assessed using CBCT analysis using fusion software. The differences between measurement times will indicate the amount of bone gain

Countries

Egypt

Contacts

CONTACTHebattallah A Mattar
hebatullah.mater@miuegypt.edu.eg201207000253
PRINCIPAL_INVESTIGATORHebattallah A Mattar

Misr International University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026